Literature DB >> 27132995

AGC1/2, the mitochondrial aspartate-glutamate carriers.

N D Amoedo1, G Punzi2, E Obre3, D Lacombe3, A De Grassi4, C L Pierri5, R Rossignol6.   

Abstract

In this review we discuss the structure and functions of the aspartate/glutamate carriers (AGC1-aralar and AGC2-citrin). Those proteins supply the aspartate synthesized within mitochondrial matrix to the cytosol in exchange for glutamate and a proton. A structure of an AGC carrier is not available yet but comparative 3D models were proposed. Moreover, transport assays performed by using the recombinant AGC1 and AGC2, reconstituted into liposome vesicles, allowed to explore the kinetics of those carriers and to reveal their specific transport properties. AGCs participate to a wide range of cellular functions, as the control of mitochondrial respiration, calcium signaling and antioxydant defenses. AGC1 might also play peculiar tissue-specific functions, as it was found to participate to cell-to-cell metabolic symbiosis in the retina. On the other hand, AGC1 is involved in the glutamate-mediated excitotoxicity in neurons and AGC gene or protein alterations were discovered in rare human diseases. Accordingly, a mice model of AGC1 gene knock-out presented with growth delay and generalized tremor, with myelinisation defects. More recently, AGC was proposed to play a crucial role in tumor metabolism as observed from metabolomic studies showing that the asparate exported from the mitochondrion by AGC1 is employed in the regeneration of cytosolic glutathione. Therefore, given the central role of AGCs in cell metabolism and human pathology, drug screening are now being developed to identify pharmacological modulators of those carriers. This article is part of a Special Issue entitled: Mitochondrial Channels edited by Pierre Sonveaux, Pierre Maechler and Jean-Claude Martinou.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AGC1; AGC2; Aralar; Aspartate; Calcium signaling; Cancer metabolism; Citrin; Energy metabolism; Glutamate; Malate-aspartate shuttle; Mitochondria; Neuron physiology; Rare diseases; Transport assays

Mesh:

Substances:

Year:  2016        PMID: 27132995     DOI: 10.1016/j.bbamcr.2016.04.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  The microRNAs miR-302b and miR-372 regulate mitochondrial metabolism via the SLC25A12 transporter, which controls MAVS-mediated antiviral innate immunity.

Authors:  Kai Yasukawa; Daisuke Kinoshita; Keisuke Yaku; Takashi Nakagawa; Takumi Koshiba
Journal:  J Biol Chem       Date:  2019-11-25       Impact factor: 5.157

Review 2.  Functional Properties of the Mitochondrial Carrier System.

Authors:  Eric B Taylor
Journal:  Trends Cell Biol       Date:  2017-05-15       Impact factor: 20.808

3.  Multiomic Profiling of Tyrosine Kinase Inhibitor-Resistant K562 Cells Suggests Metabolic Reprogramming To Promote Cell Survival.

Authors:  Brett M Noel; Steven B Ouellette; Laura Marholz; Deborah Dickey; Connor Navis; Tzu-Yi Yang; Vinh Nguyen; Sarah J Parker; David Bernlohr; Zohar Sachs; Laurie L Parker
Journal:  J Proteome Res       Date:  2019-02-21       Impact factor: 4.466

4.  Longitudinal MRI findings in patient with SLC25A12 pathogenic variants inform disease progression and classification.

Authors:  Brian C Kavanaugh; Emily B Warren; Ozan Baytas; Michael Schmidt; Derek Merck; Karen Buch; Judy S Liu; Chanika Phornphutkul; Paul Caruso; Eric M Morrow
Journal:  Am J Med Genet A       Date:  2019-08-12       Impact factor: 2.802

Review 5.  A "Weird" Mitochondrial Fatty Acid Oxidation as a Metabolic "Secret" of Cancer.

Authors:  Zhivko Zhelev; Ichio Aoki; Dessislava Lazarova; Tatyana Vlaykova; Tatsuya Higashi; Rumiana Bakalova
Journal:  Oxid Med Cell Longev       Date:  2022-02-08       Impact factor: 6.543

Review 6.  Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs.

Authors:  Vincenzo Tragni; Guido Primiano; Albina Tummolo; Lucas Cafferati Beltrame; Gianluigi La Piana; Maria Noemi Sgobba; Maria Maddalena Cavalluzzi; Giulia Paterno; Ruggiero Gorgoglione; Mariateresa Volpicella; Lorenzo Guerra; Domenico Marzulli; Serenella Servidei; Anna De Grassi; Giuseppe Petrosillo; Giovanni Lentini; Ciro Leonardo Pierri
Journal:  Molecules       Date:  2022-05-29       Impact factor: 4.927

7.  Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting.

Authors:  H Furkan Alkan; Katharina E Walter; Alba Luengo; Corina T Madreiter-Sokolowski; Sarah Stryeck; Allison N Lau; Wael Al-Zoughbi; Caroline A Lewis; Craig J Thomas; Gerald Hoefler; Wolfgang F Graier; Tobias Madl; Matthew G Vander Heiden; Juliane G Bogner-Strauss
Journal:  Cell Metab       Date:  2018-08-16       Impact factor: 31.373

Review 8.  Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.

Authors:  Ning Cheng; Jong M Rho; Susan A Masino
Journal:  Front Mol Neurosci       Date:  2017-02-21       Impact factor: 5.639

Review 9.  Human de novo purine biosynthesis.

Authors:  Vidhi Pareek; Anthony M Pedley; Stephen J Benkovic
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-11-12       Impact factor: 8.250

10.  Molecular epidemiologic study of citrin deficiency by screening for four reported pathogenic SLC25A13 variants in the Shaanxi and Guangdong provinces, China.

Authors:  Wei-Xia Lin; Muhammad Rauf Yaqub; Zhan-Hui Zhang; Man Mao; Han-Shi Zeng; Feng-Ping Chen; Wei-Ming Li; Wen-Zhe Cai; Ying-Qiang Li; Zhi-Yong Tan; Wei Sheng; Zhi-Min Li; Xiao-Ling Tao; Yuan-Xia Li; Jun-Ping Zhang; Yao-Bin Han; Yan Li; Wu-Qiong Duan; Bao-Ni Ye; Ya-Rong Li; Yuan-Zong Song
Journal:  Transl Pediatr       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.